The new map integrates data from more than 7,600 tumors across 22 independent studies and reveals previously hidden forms of breast cancer that differ in prognosis, biology and treatment sensitivity.
Vanderbilt Health researchers Adam Rosenberg, PhD (Radiology and Radiological Sciences), and Laura Kennedy, MD, PhD (Hematology and Oncology), have received a 2026 “Mars Shot” Research Award to support studies aimed at improving the diagnosis of invasive lobular carcinoma, an invasive breast cancer that is difficult to detect.
Vanderbilt Health recently honored 17 new holders of endowed directorships, six in the Department of Medicine. Seven of these endowed directorships are funded by generous donors who are passionate about making a meaningful difference in research, training and patient care.
The Nashville Area Chamber of Commerce and Young Professionals (YP) Nashville recently honored Andreana Holowatyj, PhD, MSCI, Assistant Professor of Medicine (Hematology and Oncology) at Vanderbilt Health, with a Nashville Emerging Leaders Award (NELAS). The award recognizes Middle Tennessee’s young professionals ages 21-40 across several industries for their professional achievements and community contributions.
Andrew Jallouk, MD, PhD, Assistant Professor of Medicine in the Division of Hematology/Oncology, was lead author of a new study, published Sept. 25 in Cancer Discovery, that reveals key insights into the biological factors shaping efficacy of off-the-shelf CAR-T cell therapies.
VICC will host two specialized retreats for lung care in October for colleagues across the organization to collaborate, review progress and identify opportunities to improve patient outcomes.
The ACCESS trial allowed mismatched, unrelated donors for blood cancer patients who didn’t have a perfect match for a stem cell transplant; the trial enrolled a more varied population of patients.
The disease is driven by complex combinations of multiple genetic mutations rather than a single defect, which Somedeb Ball, MBBS, Assistant Professor of Medicine in Hematology/Oncology at Vanderbilt-Ingram Cancer Center, is studying.
Department of Medicine faculty Tuya Pal, MD, and Ben Ho Park, MD, PhD, were among those awarded grants by Susan G. Komen, the internationally known nonprofit breast cancer organization.
Douglas Johnson, MD, MSCI, professor of Medicine, has been named associate director for Translational Research.
